Skip to content

Free cash flow at other companies

IAR
Integra LifeSciencesIART
-$5.05M+87.4%
MiMedx Group logo
MiMedx GroupMDXG
$1.31M-73.4%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$17.98M+176%
The Beauty Health Company logo
The Beauty Health CompanySKIN
-$5.78M-296%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.61M-35.5%
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Calculated from SANUWAVE Health, Inc.’s reported figures.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s free cash flow?
SANUWAVE Health, Inc. (SNWV) reported free cash flow of $374K in Q1 2026.
How has SANUWAVE Health, Inc.'s free cash flow changed year-over-year?
SANUWAVE Health, Inc.'s free cash flow increased by 122.3% year-over-year, from -$1.68M to $374K.
What is the long-term trend for SANUWAVE Health, Inc.'s free cash flow?
Over 3 years (2021 to 2025), SANUWAVE Health, Inc.'s free cash flow has grown at a -34.7% compound annual growth rate (CAGR), from -$6.94M to $1.93M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.